Critical role of mTOR in calcineurin inhibitor-induced renal cancer progression

Cell Cycle. 2012 Feb 15;11(4):633-4. doi: 10.4161/cc.11.4.19276. Epub 2012 Feb 15.
No abstract available

Publication types

  • Editorial
  • Research Support, N.I.H., Extramural

MeSH terms

  • Calcineurin Inhibitors*
  • Humans
  • Immunosuppressive Agents / adverse effects*
  • Immunosuppressive Agents / therapeutic use
  • Kidney Neoplasms / chemically induced*
  • Kidney Neoplasms / genetics
  • Kidney Neoplasms / metabolism*
  • TOR Serine-Threonine Kinases / genetics
  • TOR Serine-Threonine Kinases / metabolism*

Substances

  • Calcineurin Inhibitors
  • Immunosuppressive Agents
  • TOR Serine-Threonine Kinases